| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO
1 company
Watts Ryan J. is a President and CEO at DNLI. Recent filings cover 0 purchases and 122 sales.
Our model assigns Watts Ryan J. a strong insider score of 70/100, based on 33 past trades. Over a 12-month horizon, 84.4% of those trades were profitable, with an average 12-month return of +26.0%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2023 | DNLI Denali Therapeutics Inc. | President and CEO | Sale+OE | 50,000 | $31.40 | $1,570,000.00 | -2.2% | -22.1% | -33.2% | |
| Apr 21, 2023 | DNLI Denali Therapeutics Inc. | President and CEO | Sale+OE | 25,000 | $25.15 | $628,720.00 | -1.1% | +14.6% | -36.3% | |
| Feb 13, 2023 | DNLI Denali Therapeutics Inc. | President and CEO | Sale+OE | 33,815 | $30.08 | $1,017,243.35 | -1.5% | +6.1% | -43.5% | |
| Feb 10, 2023 | DNLI Denali Therapeutics Inc. | President and CEO | Sale+OE | 28,433 | $29.28 | $832,515.47 | -1.3% | -4.9% | -38.0% | |
| Jan 5, 2023 | DNLI Denali Therapeutics Inc. | President and CEO | Sell | 4,800 | $28.44 | $136,512.00 | -0.2% | -16.1% | -32.7% | |
| Jan 4, 2023 | DNLI Denali Therapeutics Inc. | President and CEO | Sell | 5,029 | $28.73 | $144,483.17 | -0.2% | -18.1% | -29.9% | |
| Aug 19, 2022 | DNLI Denali Therapeutics Inc. | President and CEO | Sell | 2,404 | $33.22 | $79,860.88 | -0.1% | -12.6% | -31.9% | |
| Feb 11, 2022 | DNLI Denali Therapeutics Inc. | President and CEO | Sell | 9,491 | $34.72 | $329,527.52 | -0.4% | -37.4% | -16.4% | |
| Feb 9, 2022 | DNLI Denali Therapeutics Inc. | President and CEO | Sale+OE | 2,719 | $37.55 | $102,103.62 | -0.1% | -40.1% | -21.7% | |
| Jan 5, 2022 | DNLI Denali Therapeutics Inc. | President and CEO | Sell | 5,007 | $44.78 | $224,213.46 | -0.2% | -25.3% | -35.5% |